Professor, Internal Medicine, University of Texas Medical School, Houston
Infectious Disease
Dr. Charles D. Ericsson, MD
|
|
Give Review
Charles Ericsson is an expert in the field of Infectious Disease. He graduated from Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He over the years received 1 awards: "Top Doctors:SE Texas". Charles Ericsson is a published doctor as well. He has 101 publications published. The latest was: Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers'' diarrhea. Charles D. Ericsson accepts all Medicare patients.
Publications
- Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia.
- Editorial note.
- Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico.
- Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico.
- Pharmacokinetic evaluation of single-dose intravenous daptomycin in patients with thermal burn injury.
- Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone.
- A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea.
- Transfusion-transmitted malaria: how satisfactory are current preventative measures?
- Nonantimicrobial agents in the prevention and treatment of traveler's diarrhea.
- Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin.
- A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea.
- Fatal amphotericin B overdose due to administration of nonlipid formulation instead of lipid formulation.
- The role of diet in the treatment of travelers' diarrhea: a pilot study.
- Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy.
- Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico.
- Therapy of travelers' diarrhea with rifaximin on various continents.
- Enteric pathogens in Mexican sauces of popular restaurants in Guadalajara, Mexico, and Houston, Texas.
- Natural history of enteroaggregative and enterotoxigenic Escherichia coli infection among US travelers to Guadalajara, Mexico.
- Letter: Susceptibility to group B meningococcal vs. Escherichia coli Kl disease.
- Comparative studies of antibiotic therapy after penetrating abdominal trauma.
- Kidney donors don't regret: follow-up of 370 donors in Stockholm since 1964.
- New focus of Chagas'' disease in Mexico.
- Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review.
- Mechanisms of host defense in well nourished patients with chronic alcoholism.
- Sequential CSF concentration of chloramphenicol after administration of oral chloramphenicol palmitate.
- Infections of the upper respiratory tract.
- Pleural effusion in histoplasmosis.
- Systemic absorption of bacitracin after peritoneal lavage.
- Clinical pharmacology of intravenous and intraperitoneal aminoglycoside antibiotics in the prevention of wound infections.
- Intraventricular and parenteral gentamicin therapy for ventriculitis in children.
- Effect of chemotherapeutic agents on metabolic and bactericidal activity of polymorphonuclear leukocytes.
- Erroneous diagnosis of meningitis due to false-positive gram stains.
- Minocycline treatment failure in pneumonia caused by minocycline-sensitive Streptococcus pneumoniae.
- Cryptosporidium and diarrhea.
- Nosocomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: results of the case-control and molecular epidemiologic investigations.
- Travel medicine: key to improved adult vaccination against Hepatitis A and B.
- Latex agglutination-negative methicillin-resistant Staphylococcus aureus recovered from neonates: epidemiologic features and comparison of typing methods.
- Comparative bioavailability of intravenous and oral chloramphenicol in adults.
- Gentamicin and ticarcillin levels.
- Prophylactic antibiotics in trauma: the hazards of underdosing.
- Native valve endocarditis due to Bartonella henselae in a middle-aged human immunodeficiency virus-negative woman.
- Special section:travel medicine.
- Antisecretory and antiinflammatory properties of bismuth subsalicylate.
- Absorption of salicylate and bismuth from a bismuth subsalicylate--containing compound (Pepto-Bismol).
- Salicylate absorption from a bismuth subsalicylate preparation.
- Influence of subsalicylate bismuth on absorption of doxycycline.
- Fecal leukocytes in enteric infections.
- The relation between production of cytotoxin and clinical features in shigellosis.
- Bacterial gut infections.
- Incidence of bacterial enteropathogens in foods from Mexico.
- Contaminated stethoscopes revisited.
- Prevention and empiric treatment of traveler's diarrhea.
- Safety and efficacy of loperamide.
- Chemotherapy and chemoprophylaxis of travelers' diarrhea.
- Travelers' diarrhea: can it be eluded?
- Current problems in antimicrobial therapy for bacterial enteric infection.
- Antimicrobial therapy for travelers' diarrhea.
- Seroconversion to Entamoeba histolytica among short-term travelers to Mexico.
- Chemoprophylaxis and chemotherapy of travelers' diarrhea in children.
- Travelers' diarrhea. Prevention and treatment.
- Antimicrobial agents in the prevention of travelers' diarrhea.
- Clinical presentation as a guide to therapy for travelers' diarrhea.
- Emporiatric enteritis: lessons learned from U.S. students in Mexico.
- Antimicrobial therapy of travellers'' diarrhoea.
- Bismuth subsalicylate inhibits activity of crude toxins of Escherichia coli and Vibrio cholerae.
- Travelers' diarrhea. Epidemiology, prevention, and self-treatment.
- Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth).
- Efficacy of bicozamycin in preventing traveler's diarrhea.
- Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate.
- Human rotavirus in an adult population with travelers'' diarrhea and its relationship to the location of food consumption.
- The role of location of food consumption in the prevention of travelers' diarrhea in Mexico.
- Nonantibiotic therapy for travelers' diarrhea.
- Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers' diarrhea.
- Enteroadherent Escherichia coli associated with travellers'' diarrhoea.
- Intestinal secretory immunoglobulin A response to enteroaggregative Escherichia coli in travelers with diarrhea.
- Comparison of methods to detect Escherichia coli heat-labile enterotoxin in stool and cell-free culture supernatants.
- Acute diarrhea in developed countries. A rationale for self-treatment.
- Bacteriological studies of the enteric flora of patients treated with bicozamycin (CGP 3543/E) for acute nonparasitic diarrhea.
- Reactive arthritis associated with typhoid vaccination in travelers: report of two cases with negative HLA-B27.
- Lack of emergence of resistant fecal flora during successful prophylaxis of traveler's diarrhea with norfloxacin.
- Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blin...
- Role of a novel antidiarrheal agent, BW942C, alone or in combination with trimethoprim-sulfamethoxazole in the treatment of traveler's diarrhea.
- Furazolidone versus ampicillin in the treatment of traveler's diarrhea.
- A cost-effectiveness comparison of the use of antimicrobial agents for treatment or prophylaxis of travelers' diarrhea.
- Prevention and treatment of traveler's diarrhea.
- Zaldaride maleate, an intestinal calmodulin inhibitor, in the therapy of travelers' diarrhea.
- Rifaximin: a new approach to the treatment of travelers'' diarrhea. Conclusion.
- Trimethoprim/sulfamethoxazole remains active against enterotoxigenic Escherichia coli and Shigella species in Guadalajara, Mexico.
- Rifaximin: a new approach to the treatment of travelers'' diarrhea. Introduction.
- Emergence of trimethoprim-resistant Escherichia coli in healthy persons in the absence of prophylactic or therapeutic antibiotics during travel to Guadalajara, Mexico.
- Use of bismuth subsalicylate for the prevention of travelers' diarrhea.
- Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers'' diarrhea.
- Bicozamycin, a poorly absorbable antibiotic, effectively treats travelers' diarrhea.
- Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial.
- A newly recognized cause of travelers' diarrhea: enteroadherent Escherichia coli.
- Treatment of traveler's diarrhea with sulfamethoxazole and trimethoprim and loperamide.
- Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico.
- Occurrence of Norwalk virus infections among adults in Mexico.
- Travelers' diarrhea: approaches to prevention and treatment.
- Shigella sonnei strains isolated from U.S. summer students in Guadalajara, Mexico, from 1986 to 1992.
Schools
Harvard Medical School
University Minn Hospital
University Tex Hospital
Doctors Specialties
- Internal Medicine
- Infectious Disease
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Assurant Health
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Houston Area HMO-Standard
- Medicaid
- Medicare MCR
- MHealth Insured
- Molina
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Top Doctors:SE Texas
Education
-
University of Minnesota at Fairview -
Harvard Medical School
Drug Facts
| NPI NUMBER | 1477571941 | |
| NPPES Provider LastName | ERICSSON | |
| NPPES Provider FirstName | CHARLES | |
| NPPES Provider ZIPCode | 770303000 | |
| NPPES Provider State | TX | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 143.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1477571941 |
| Last Name Of The Provider | ERICSSON |
| First Name Of The Provider | CHARLES |
| View All |
Similar Doctors
|
Dr. Pornthep Wattanamano, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charanjeev K. Mann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allison P. Heinen, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Barry J. Zeluff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Herbert L. Dupont, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frederick J. Buckwold, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel Shelburne, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth V. Rolston, MD
This Doctor is OpenDoctor Recommended.
|